Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Thoma Cressey Bravo, Inc. (CIK 1270210) reported $59.3M across 2 reported positions in its SEC 13F filing for 2013-09-30. Largest positions: JAZZ ($32.9M, 55.45%), SEM ($26.4M, 44.55%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | JAZZ | Jazz Pharmaceuticals PLC | $32.9M | 55.45% | 357,230 | Trimmed |
| 2 | SEM | Select Med Hldgs Corp | $26.4M | 44.55% | 3.3M | Hold |
Source: SEC Form 13F filings · as of 2013-09-30